Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03884660 · ClinicalTrials.gov registry record
remedē System Therapy Study
A clinical trial of Central Sleep Apnea, sponsored by Respicardia.
- Active
- Registry status
- 225
- Enrollment target
- 20
- Study locations
NCT03884660: Active study of Central Sleep Apnea, sponsored by Respicardia.
NCT03884660 is a study of Central Sleep Apnea that is active but no longer recruiting, run by Respicardia. The registered enrollment target is 225 participants, above the 94-participant average among 4 other Central Sleep Apnea trials with a reported enrollment target (139% higher). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03884660, a study of Central Sleep Apnea, is active but no longer recruiting, sponsored by Respicardia.
- ACTIVE NOT RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.
Primary Outcome
Proportion of subjects with peri-operative and long-term serious adverse events (SAEs) related to the remedē System implant procedure, device or delivered therapy
Conditions Studied
Interventions
- DEVICE remede System
Study Locations (20)
Arizona
- Banner University Medical Center - Phoenix
- Arizona Heart Rhythm Center - Phoenix
- HonorHealth - Scottsdale
North Carolina
- Novant Health - Charlotte - Charlotte
- East Carolina University - Greenville
- Novant Health Forsyth Medical Center - Winston-Salem
Colorado
- University of Colorado- Anschutz - Aurora
- University of Colorado Health - Fort Collins
New York
- Northwell Health - New Hyde Park
- New York Presbyterian Hospital-Weill Cornell Medicine - New York
California
- The University of California San Francisco - San Francisco
Florida
- Central Florida Pulmonary Group - Orlando
Georgia
- Emory University Midtown Hospital - Atlanta
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2030-12-30 |
What the registry record for NCT03884660 still lists
NCT03884660 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 94-participant average among 4 other Central Sleep Apnea trials with a reported enrollment target (139% higher).
The record links to 1 condition, with Central Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which remede System is the first listed.
NCT03884660 names 20 study sites across 14 states, led by Arizona, North Carolina, Colorado.
Frequently Asked Questions
What is clinical trial NCT03884660 about?
NCT03884660 is a clinical study titled "remedē System Therapy Study". The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.
What is the current status of trial NCT03884660?
This trial is currently active not recruiting. The enrollment target is 225 participants. The study started on 2019-06-18. Estimated completion is 2030-12-30.
What conditions does trial NCT03884660 study?
This clinical trial studies the following conditions: Central Sleep Apnea.
What interventions are being tested in trial NCT03884660?
The interventions under investigation include: remede System (DEVICE).
Who is sponsoring clinical trial NCT03884660?
This trial is sponsored by Respicardia, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03884660 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI